FindTrial
Sign In

Assessment the effect of Vrudhadaruka (Argyreia speciosa Sweet. ) in the management of Aamavata.

Phytochemical and pharmacotherapeutic evaluation of Vrudhadaruka (Argyreia speciosa Sweet. ) in the management of Aamavata (Rheumatoid arthritis) - NIL

Status
Unknown
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085096
Enrollment
30
Registered
2025-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M058- Other rheumatoid arthritis with rheumatoid factor

Interventions

None listed

Sponsors

Deparment of dravyaguna POST GRADUATE INSTITUTE OF AYURVEDA DSRRAU JODHPUR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.The Patients between the age group of 35 to 60 years in both sexes presenting with clinical features of Aamavata. 2. Clinically diagnosed and confirm patients on Aamavata. 3. RA Factor Positive 4. Patients willing to sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Patients of uncontrolled diabetes mellitus, severe anaemia, having any type of malignancy etc. 2. Patients having Neoplasm of spine, Gout, Ankylosing Spondylitis, Traumatic Arthritis, Pyogenic Osteomyelitis etc. 3. Patients having any other severe disease like Cardiac disease, Renal failure, Hypertension etc. 4. Pregnant women and lactating mother. 5. Patient below age of 35 years & above 60 years.

Design outcomes

Primary

MeasureTime frame
Changes in objective parametersTimepoint: 60 days—

Secondary

MeasureTime frame
Changes in objective parameter.Timepoint: 60 days—

Countries

India

Contacts

Public ContactDr Rajendra prasad purvia

Deparment of dravyaguna POST GRADUATE INSTITUTE OF AYURVEDA DSRRAU JODHPUR

dandiasuresh80@gmail.com8385853115

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026